Veronique Servent
Lille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Treatment and outcomes of older versus younger women with HER2-positive metastatic breast cancer in the real-world national ESME database.
Journal: Breast (Edinburgh, Scotland)
Published: July 04, 2021
Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial.
Journal: Breast cancer research : BCR
Published: July 03, 2019
Effects of a physical activity programme to prevent physical performance decline in onco-geriatric patients: a randomized multicentre trial.
Journal: Journal of cachexia, sarcopenia and muscle
Published: April 24, 2018
New advances in DPYD genotype and risk of severe toxicity under capecitabine.
Journal: PloS one
Published: December 02, 2016
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 16, 2015
EGFR-Mutated Breast Metastasis of Lung Adenocarcinoma: A Case Report.
Journal: Case reports in oncology
Published: April 16, 2015
Brain Metastases of Her2-Positive Breast Cancer: A Case of 34 Months' Remission with Lapatinib plus Capecitabine.
Journal: Case reports in oncology
Published: September 19, 2014
Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer.
Journal: International journal of cancer
Published: June 30, 2014
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 30, 2014
A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer.
Journal: Journal of neuro-oncology
Published: October 25, 2012
Pertuzumab monotherapy after trastuzumab-based treatment and subsequent reintroduction of trastuzumab: activity and tolerability in patients with advanced human epidermal growth factor receptor 2-positive breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 07, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026